INTRODUCTION
Genome-wide association studies (GWAS) for common inherited human diseases have shed light on novel candidate genes [1] , which often lack functional characterisation to understand their role in disease pathogenesis. Growing evidence from GWAS data supports the involvement of common risk loci in diseases characterized by distinct pathophysiological features, suggesting that genes at these loci contribute to shared disease etiology through mechanisms of cross-phenotype association and pleiotropy [2, 3] . This phenomenon is illustrated with common risk loci in autoimmune and immune-mediated inflammatory diseases [4, 5] , and recently extended to genetic variants shared in cancer and blood triglycerides and low-density lipoprotein cholesterol [6] .
The GLIS family zinc finger 3 isoform (GLIS3) is among the most replicated GWAS signals for diabetes mellitus and related metabolic traits. It is one of the few identified GWAS risk genes for both type 1 [7] [8] [9] and type 2 [10] [11] [12] diabetes. GWAS have shown that common variants within GLIS3 itself are also associated with cerebrospinal fluid Tau [13] , a biomarker in Alzheimer's disease, glaucoma [14] and serum levels of the thyroid stimulating hormone [15] . Patients with mutations in GLIS3 exhibit neonatal diabetes and congenital hypothyroidism [16, 17] , but they also show a much broader spectrum of clinical manifestations, including hepatic, renal and cardiac diseases and skeletal abnormalities [16] [17] [18] . These data strongly suggest that genetic variations and mutations in GLIS3 have strong cross phenotypic effects in distinct organs.
GLIS3 is a component of Krüppel-like zinc finger transcriptional regulators that share a highly conserved five-C 2 H 2 -type zinc finger. It is expressed in many organs where it controls gene transcription through Glis3-binding sites (G3BS) in regulatory regions of target genes [19] . GLIS3 plays a critical role in the development and function of pancreatic β-cells, as shown for many type 2 diabetes GWAS genes [20] . Consistent with its primary etiological
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4 role in diabetes, it regulates fasting glucose and insulin [21, 22] and glucose-stimulated insulin release [23] . Glis3 disruption in mice causes neonatal diabetes and hypothyroidism [24] [25] [26] . Glis3-null pups are hyperglycemic and die prematurely. Glis3 mutant mice exhibit small islets, with strongly decreased number of β-and δ-cells. Several studies indicate that
Glis3 indirectly regulates expression of key transcription factors (Pdx1, NeuroD1, MafA) required for the development of the endocrine pancreas and the function of mature β-cells [24, 26, 27] and is implicated in β-cell survival [28] .
Despite the key role of GLIS3 in diabetes etiology and in endocrine pancreas development, molecular and cellular mechanisms mediating its function remain largely unknown. To understand diabetes-related mechanisms regulated by GLIS3 in β-cells, we carried out genome-wide chromatin immunoprecipitation sequencing (ChIPseq) of G3BS in INS1 cells, which derive from rat pancreatic β-cells, followed by molecular and physiological studies 
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MATERIALS AND METHODS
GLIS3 chromatin immuno-precipitation and sequencing
About 1x10 7 We obtained over 20M and about 37M reads in IP and Input, respectively. Raw sequence data have been deposited in ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) under the accession number E-MTAB-5454.
Sequence alignment was performed using Bowtie. Peak calling performed with MACS2
(https://github.com/taoliu/MACS/wiki/Install-macs2) identified 299 peaks with sizes ranging from 134nt to 1656nt. Peak sequences were searched for DNA motifs using Dimont, RSAT (Peak-motifs), GimmeMotifs and completeMotifs [29] . RSAT was used on the 299 sequences restricted to the 200bp around the peak summits. Motifs were considered as significant when binomial significance ≥ 10. Twelve tools were considered (Mdmodule, MEME,
MotifSampler, trawler, Improbizer, BioProspector, Posmo, ChIPMunk, JASPAR, AMD, HMS, GADEM). For this analysis, 90% of the full-length sequences were used to predict motifs while 10% were used to compute p-values (only motifs with a p-value < 0.001 and enrichment > 1.5 were retained). CompleteMotifs was used to combine four different tools, PATSER, MEME, Weeder and ChiPMunk. One motif with the consensus sequence wrGTTCCCArTAGs was found in the top motifs of all four tools.
Cell systems
A C C E P T E D M A N U S C R I P T containing DMEM, 1% horse serum and NGF (100ng/ml).
Animals
Colonies of Goto-Kakizaki (GK/Ox) and Brown Norway (BN) rats were bred locally. The congenic strain BN.GK-Glis3-Ric1 (referred as BN.GK-1k throughout the text) was derived using a genetic marker assisted breeding strategy ("speed congenics") and maintained as previously described [31] . This congenic was designed to contain GK alleles at the Glis3 locus onto the genetic background of the BN strain. Rats were allowed free access to tap water and standard laboratory chow pellets (R04-40, Safe, Augy, France) and were maintained on a 12-h light-dark cycle. All experiments were carried out with six month old male congenic and control rats. All animal procedures were performed under a UK Home
Office licence approved by the ethical review panel of the University of Oxford and authorised by the Charles Darwin Ethics Committee in Animal Experiment, Paris, France.
Glucose-induced insulin secretion in vivo
Insulin secretion tests were performed by intravenous injection of glucose (0.8g /kg body wt)
in rats fasted for 4 hours in the morning (post absorptive state) using the protocol applied to
the phenotypic screening of the GKxBN F2 hybrids [32] . Plasma immunoreactive insulin was assayed using an ELISA kit (Mercodia, Uppsala, Sweden).
Static incubation of pancreatic islets
BN.GK-1k congenic and BN rats were killed by cervical dislocation. Collagenase (Sigma Aldrich, Saint Quentin Fallavier, France) was rapidly injected into the ligated pancreatic duct and pancreas was excised for pancreas digestion. Islets were isolated using a stereomicroscope. Insulin secretion was measured in static incubation following overnight culture in RPMI1640 containing 5mM glucose. Groups of 10 size-matched islets were preincubated prior to treatment with 1, 12 and 20mM glucose. Islets were then incubated for 1 hr at 37°C and the supernatant removed for analysis. Insulin was assayed using an ELISA kit (Mercodia, Uppsala, Sweden).
Glucose-induced insulin secretion in vitro in INS1 cells
Rat insulinoma 832/13 INS1 cells were maintained in a glucose-free culture medium prior to incubation in a solution containing 2.8mM or 16.7mM of glucose. Immunoreactive insulin was determined by ELISA (Mercodia, Uppsala, Sweden) on supernatants and protein content was measured on cells.
Immunohistochemistry
Pancreata from 4-weeks old Wistar rats were fixed in 4% paraformaldehyde and embedded in paraffin. Paraffin sections (7µm) were prepared. Adjacent sections were incubated with primary antibodies: guinea-pig anti-porcine insulin (1:1000, ICN pharmaceutical, Orsay, France), rabbit antirecombinant glucagon (1:1000, Vector, Peterborough, UK) or custom made anti-rat GLIS3 (1:1000, Eurogentec, Angers, France).
Primary cultures
Hippocampi were dissected from embryonic day 18 or 19 Sprague Dawley rats. Tissue was trypsinized and neurons were plated at a density of 2.3 × 10 4 cells/cm 2 . After attachment for 
Imaging of cultured hippocampal neurons
Experiments were carried out with cultured hippocampal neurons 72-96 h after transfection.
Imaging was obtained on a Leica SP5 confocal microscope with a 40X water objective. The number of dendrite branches crossing concentric circles around the soma was automatically counted using Fiji Sholl analysis plugin. Spine density was determined manually using single cell labelling on 3 medial branches by neuron.
Protein analyses
Total protein extracts were transferred to nitrocellulose membranes and incubated with rabbit DAKO, Ely, UK) and goat anti-mouse (1:2,000; Pierce, Cramlington, UK).
Glis3 sequencing and SNP validation
Glis3 polymorphisms were validated by sequencing genomic DNA from BN and GK strains.
PolyPhen-2 v2.2.2r398 (http://genetics.bwh.harvard.edu/pph2) [33] was used to predict the potentially damaging consequences of the polymorphisms found in Glis3.
Real time quantitative PCR
Total RNA was prepared with RNeasy kit (Qiagen, Crawley, UK). Real-time quantitative PCR (q-PCR) was performed on a Rotor Gene 6000 (Corbett Research, Milton, UK) and the results were normalized to the house keeping gene. cDNA was amplified by real-time q-PCR with Quantitect SYBR Green PCR mastermix (Qiagen, Crawley, UK). Four to six biological replicates were analysed and each sample was analysed in triplicate. Oligonucleotides designed for PCR are given in Table S1 .
Statistical analyses
Statistical analyses were performed using SPSS software version 17. 
Comparative genome analysis of G3BS and relationships to GWAS
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Analysis of synteny conservation between rat and human genomes was carried out for genes associated with 163 of the 169 G3BS clusters defined in Table S2 . Comparative analysis of genes directly associated with GLIS3 binding sites in the rat and human genomes was used as initial anchor synteny points in the two species, which were further ascertained using the genomic position of flanking genes. We considered human orthologs flanking G3BS, and immediately adjacent genes when mapped within 100Kb of G3BS (Table S3) Table S4 .
Pathway analysis of genes associated with GLIS3 binding sites.
The list of genes associated with GLIS3 binding sites were submitted to Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com) for pathway enrichment analysis and to the Database for Annotation, Visualisation and Integrated Discovery (DAVID, https://david.ncifcrf.gov) for gene functional annotation using Gene Ontology (GO) terms.
IPA and DAVID top ranked pathways and functional group of genes to be studied were selected based on the rank, the score and the p-value. Since this is an exploratory approach, and the main pathways identified were independently validated experimentally, the p-values displayed were not corrected for multiple testing.
RESULTS
GLIS3-mediated transcriptional landscape in β-cells
To understand diabetes-related mechanisms regulated by GLIS3 in β-cells, we carried out genome-wide chromatin immunoprecipitation sequencing (ChIPseq) of GLIS3 binding sites (G3BS) in cultured insulin secreting INS1 cells. Read-enriched regions from the ChIP-Seq identified 299 putative G3BS (q<0.05; enrichment range 1.40-9.11 fold), which we grouped in 169 clusters (Table S2 ) evenly distributed across the genome ( Figure S1 ). Over 65% of G3BS (195/299) and 70% of G3BS clusters (118/169) which could be mapped to the rat genome assembly were localised within 50kb of a protein coding sequence ( Figure 2A ). As expected, we showed that several genes close to G3BS are involved in β-cell development (Pdx1) and function (Insr, Kcnj6, Slc2a2) (Table S2) . Quantitative PCR for a selection of 14 genes chosen for their tight linkage to putative G3BS validated significant chromatin enrichment for 10 loci tested ( Figure S2 ).
Genomic sequences from the ChIP-Seq were searched for common DNA sequence motifs that could represent consensus binding sites for GLIS3. One motif with the consensus sequence, wrGTTCCCArTAGs was found in the top motifs of all four tools used (PATSER, MEME, Weeder, ChiPMunk). We confirmed the enrichment of previously proposed GLIS3
binding motifs G(T/C)CCCC(T/A)GCTGTGA(A/G) and (G/C)TGGGGGGGT(A/C) using
Find Individual Motif Occurences (FIMO) and MEME [34, 35] (Table S5) . Sixty-eight occurrences of the former where found in 54 peak sequences (p-value < 0.0001) and eighteen occurrences of the latter where found in 14 peak sequences (p-value < 0.0001) (Table S5 ). In addition, based on our sequencing data, the motif wrGTTCCCArTAGs also emerged from all software used as a new consensus DNA sequence for G3BS ( Figure 2B ).
Biological pathway analysis suggests dual pathophysiological role of GLIS3 in β-cells and neurons
We initially used function and pathway annotations available for genes containing or immediately adjacent to G3BS to predict functional aspects of GLIS3 biology. Results from Ingenuity Pathway Analysis (IPA) revealed its anticipated predominant role in metabolic function and diseases, even though the effects were not significant when corrected for multiple testing. A total of 60 genes associated with G3BS contributed to enrichment of functions involved in endocrine system development and function and in metabolic and endocrine system diseases (Table 1A) . Interestingly, IPA also identified enrichment of functions directly relevant to other disease areas, including neurobiology through nervous system development and function (Table 1A) . Results from DAVID pathway enrichment analysis (http://david.abcc.ncifcrf.gov) confirmed this finding with the identification of genes close to G3BS that contributed to statistically suggestive enrichment of the pathways synapse
, Nsf, Gnat3) (p=0.008) and synaptic transmission (Hrh1, Grik1, Grik3, Erc2, Nsf) (p=0.049) (Table 1B) . G-profiler also identified genes associated with G3BS contributing to the suggestive enrichment of the pathway neuron part
). This unexpected finding obtained with insulin secreting cells INS1 is supported by co-expression of GLIS3 in brain, specifically in the hippocampus in the mouse ( Figure 2C ; Figure S3 ), and in pancreatic β-cells in the rat ( Figure 2D ). α-cells expressing glucagon were predominantly peripheral to the islets and evidence of co-straining for GLIS3 and insulin indicate that GLIS3 is expressed specifically in β-cells. These observations suggest that GLIS3 may also have a role in neuronal function and in diseases of the nervous system. Analysis of GLIS3
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13 expression in the developing mouse brain supports its presence throughout hippocampal development ( Figure S4 ).
To assess dual etiological roles of GLIS3 in metabolic and neurological diseases, we searched genes localised close to G3BS in the NHGRI-EBI catalog of published GWAS (www.ebi.ac.uk/gwas) for evidence of association with disease status and disease intermediate phenotypes. Following analysis of synteny conservation of G3BS clusters defined in Table S3 in the human genome, we identified 375 cases of genetic associations between genes at 127 G3BS and various phenotypes and disease traits ( Table 2, Table S3 ).
Interestingly, even though genetic associations to cancer phenotypes in the GWAS archive are more frequent than those to any other disease category, we found a statistically significant (p<2.2 x 10 -16 ) enrichment of G3BS linked to genes associated with phenotypes relevant to cardio-metabolic diseases (n=89 for 27,982 associations; OR=6.8) and neuro-behavioural pathologies (n=72 for 15,326 associations; OR=10.1) when compared to cancer (n=23 for 49,324 associations). In a large number of cases (27) , there was consistent association between genes at G3BS and both cardio-metabolic and neuropathological phenotypes. This finding was particularly significant for prime candidates for diabetes (Pdx1) or schizophrenia and Alzheimer's disease (Disc1) and replicated signals for different traits (eg. Macrod2, Grik1) ( Table 2 ).
GLIS3 regulates gene transcription in β-cells and neurons
To provide experimental evidence for GLIS3-mediated transcriptional regulation of genes associated with G3BS and to test the hypothesis that G3BS signals originally detected in 
Glis3 regulates the expression of genes involved in autophagy
Results from pathway analysis also pointed to molecular mechanisms that may explain cross phenotype association mediated by GLIS3. Using DAVID (http://david.abcc.ncifcrf.gov), we showed that Atg4c, Atg7 and Atg12, which contain, or are immediately adjacent to, G3BS
contributed to suggestive enrichment of the pathway autophagy (GO:0006914; Enrichment Score 1.46; p=0.01) (Table 1 ), a fundamental mechanism that degrades cytoplasm constituents. The pathway regulation of autophagy in KEGG (rno04140) was also the top ranking pathway enriched when analyses were carried out with DAVID (p=0.018) and Gprofiler (p=0.05). GLIS3-mediated regulation of autophagy in both β-cells and neurons was supported by cell-specific GLIS3-reactive transcription of Atg7 and Atg4a in INS1 and PC12
( Figure 3A ,B).
To establish the regulatory role of GLIS3 in autophagy, we initially quantified autophagic markers LC3-I and LC3-II in INS1 and PC12 overexpressing Glis3 ( Figure 3C,D) . resulted in a 50% reduction in Glis3 mRNA level ( Figure 3E ). SiRNA-mediated GLIS3
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knock-down was associated with a significant decrease in abundance of LC3-I and LC3-II ( Figure 3E ). In contrast, stimulated expression of Glis3 in PC12 cells was associated with significant reduction of both abundance of LC3-I and LC3-II and conversion of LC3-I to LC3-II ( Figure 3D ). To examine whether stimulating autophagic flux would protect betacells, we used the autophagy-enhancing drug carbamazepine [36] , which may promote increased clearance of autophagosomes [37] . insulin signalling [40] and neurodegenerative disease [41] . In addition, GLIS3-reactive expression of Atg4a was abolished in these cells ( Figure 4B ).
We then investigated the potential impact of Glis3 naturally occurring variants in autophagy.
Stimulatory effect of GLIS3 on LC3-II abundance and in LC3-II/LC-I ratio in INS1 cells remained significant when cells were transfected by GK allele of Glis3 ( Figure 4C ) as previously observed with BN Glis3 alleles ( Figure 3C ). In contrast, transfection of the GK allele of Glis3 in PC12 cells induced a sharp increase in the expression of LC3-I and LC3-II ( Figure 4D ), which contrasts with the inhibitory effect of the wild type allele of Glis3 on these markers in these cells ( Figure 3D ).
We further complemented functional aspects of GLIS3 established in cell lines with ex vivo data derived from primary cultures of hippocampus neurons and pancreatic islets and in vivo experiments in congenic rats.
Effects of naturally-occurring polymorphisms in Glis3 on insulin secretion and neuron architecture
To test the impact of GK DNA variants in Glis3 and associated gene transcription changes on Figure 5B,C), which contrasts with the effect of Glis3 in PC12, probably due to differences in cell systems used. In contrast, stimulated expression of GK Glis3 led to significant reduction in neuron soma size ( Figure   5B ,C). We carried out further quantitative analysis of neuron morphology using the Sholl method, which determines the number of dendrite intersections for gradually increasing concentric circles from the soma centre. We were able to demonstrate that the GK variants of Glis3 are associated with significant reduction of both dendritic complexity ( Figure 5D ) and spine density ( Figure 5E ), which are key neuronal features in neurodegenerative diseases.
These data support the biological role of Glis3 in the regulation of gene expression in neurons and demonstrate the strong impact of GK naturally occurring polymorphisms on β-cell function and on neurite growth and morphology.
The GK haplotype in BN.GK-1k congenics is associated with enhanced insulin secretion in vitro and in vivo and suggestive evidence of increased autophagy in brain and in pancreas
To further validate our findings in an in vivo system, we analysed glucose-induced insulin secretion and autophagy in rats of the congenic strain BN.GK-1k, which contains a short genomic region of chromosome 1 (1.31Mb) of GK origin, including Glis3 and 13 additional genes, introgressed onto the genomic background of the BN strain ( Figure 6A ). Rats of the congenic strain exhibited a modest but statistically significant (p<0.01) increase in insulin secretion in response to glucose in vivo ( Figure 6B ). Basal insulin levels in vivo and in vitro
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in isolated islets were similar in BN.GK-1k and BN rats ( Figure 6B,C) . In vitro insulin secretion by islets isolated from BN rats was stimulated by 12mM and 20mM glucose.
Glucose stimulated insulin secretion in vitro by incubated islets was higher in BN.GK-1k congenic rats than in BN controls and this effect was statistically significant (p<0.05) in response to 20mM glucose ( Figure 6C ).
We then analysed markers of autophagy in total pancreas and whole brain in BN, GK and BN.GK-1k rats. Conversion of LC3 was significantly increased in GK pancreas (p=0.0001) and brain (p=0.04) when compared to BN controls ( Figure 6D ,E). This effect was replicated in BN.GK-1k congenic rats, which exhibited significantly higher conversion of LC3 than BN controls in both pancreas (p=0.023) and brain (p=0.019) ( Figure 6D ,E). The effect of GK variants of Glis3 on the stimulation of autophagy is conserved in the pancreas and whole brain of GK and congenic rats (Fig 6D,E) , whereas discordant results are obtained in INS1
and PC12 transfected with the GK alleles of Glis3 (fig3C,D), suggesting differential regulation at the organ level and in cultured cells.
Collectively, these data provide in vivo experimental validation of our in vitro results and suggest that Glis3 variants may account for GK phenotypes originally mapped in GKxBN F2 cross.
Discussion
We have established a genome-wide inventory of DNA binding sites for the transcription factor GLIS3 in insulin secreting cells, which were often located in the close vicinity of loci associated with metabolic and neurological disorders in GWAS and genes involved in autophagy and neuron function. We confirmed experimentally the role of GLIS3 on gene transcription in β-cells and neurons. Naturally-occurring non synonymous variants in Glis3 in the GK model of type 2 diabetes (T2D) were associated with enhanced insulin secretion in vivo and in vitro, deteriorated morphology of hippocampus neurons, differential expression of key autophagy genes in insulin secreting cells and in neurons and up-regulated autophagy marker in brain and pancreas.
Genome-wide occupancy data of GLIS3 in INS1 cells allowed prediction of a comprehensive collection of target genes of this transcription factor, which complements information from gene expression studies in experimental systems. Our data confirm the documented regulation of SLC2A2 [28, 42] , which occurs through its direct interaction with DNA elements at this locus. The existence of G3BS at the PDX1 locus is consistent with data from our group showing that GLIS3 regulates PDX1 expression [28] , but contradicts other reports that failed to show an effect of GLIS3 on PDX1 expression [35, 42] . In addition, we did not find evidence of statistically significant enrichment of G3BS for genes known to be regulated by GLIS3 (insulin, neurogenin 3, cyclin D2) [26, 42, 43] . In particular, we were unable to replicate significant enrichment for G3BS sequences identified by electrophoretic mobility shift assay (EMSA) upstream genes encoding insulin [26, 35] and neurogenin 3 [43] , which may be explained by differences in cellular material and in experimental procedures used in the studies. These may also explain the lack of G3BS identified in our study close to the vast majority of genes shown to be regulated by GLIS3 [26, 35, 42] and differentially expressed in
pancreas of Glis3 mutant mice [26] , suggesting that a proportion of the transcriptional effects of GLIS3 may be species specific or indirect consequences of Glis3 inactivation.
Enriched DNA occupancy of GLIS3 at risk loci associated with metabolic and neurological diseases in GWAS supports frequent observations of genomic co-localization of risk genes for diseases characterised by distinct pathogeneses and target organs. This phenomenon of cross phenotype association [2] is well illustrated with T2D which shares common risk loci with autoimmune diseases [5] , Crohn's diseases [3] , osteoporosis [44] and Alzheimer's disease (AD) [13, 45] . Even though causal relationship between T2D and AD is debated [46] , T2D is a risk factor for AD and etiological connections between these diseases are supported by epidemiological and experimental evidence of mechanistic relationships [47, 48] . Patients with T2D have an increased risk of developing depression and AD when compared to individuals without T2D [49] and T2D is associated with more severe cognitive impairment in Parkinson disease [50] . Reciprocally, 80% of AD patients have glucose intolerance or T2D [49] and patients with schizophrenia exhibit greater risk of developing diabetes [51] . The identification of GLIS3 variants associated with diabetes and with an AD endophenotype [13] , evidence of mental impairment in GLIS3 mutated patients [16, 17] and synapse formation [52, 53] and DISC1 variants have been consistently implicated in schizophrenia, bipolar disorder, major depression and autism [52] . Interestingly, Disc1 downregulation in mice results in decreased β-cell proliferation, glucose intolerance, reduced insulin secretion and Pdx1 expression [54] . Other genes involved in neuron function and neuropathologies (Grik1, Grik3, Ube3a, Grinl1a, Sptlc1, Dyrk1a, Rimklb) are associated with G3BS and contribute to enrichment of the neuron biological pathway. Glutamate receptors GRIK1 and GRIK3 modulate synaptic transmission and are associated with epilepsy, schizophrenia, AD and depressive disorder [55] . The E3 ubiquitin ligase UBE3A is critical for the processes of learning, memory and synaptic plasticity, and deficient expression of the maternal copy in the brain causes Angleman Syndrome, a neurodevelopmental disorder combining intellectual disability and seizures [56] . GRINL1A, SPTLC1 and DYRK1A are differentially expressed in brain of patients with AD [57] [58] [59] and RIMKLB is involved in schizophrenia through the regulation of N-acetyl-aspartylglutamate synthesis [60] .
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Autophagy is a common mechanism in β-cells and neurons in diabetes and neuropathologies.
Enhanced autophagy is associated with β-cell death in T2D [61] and may protect β-cells against palmitate-induced apoptosis [37] . It suppresses neurite degeneration in PC12 cells [62] and has a neuroprotective role in AD [63] . These data suggest context-dependent regulation of autophagy in β-cells and neurons and may explain the broad and contrasting effects of GLIS3 stimulation on autophagy marker LC3II/I in INS1 and PC12 in the present study, which remains to be further characterised by the analysis of autophagy flux. The most significant autophagy gene which is differentially regulated in GLIS3 transfection experiments is ATG7, an essential component in autophagosome formation. Investigations in organ-specific Atg7 knock-out mice demonstrated its causative role in glucose intolerance, impaired islet structure and neurodegenerative symptoms [64] . The Pdx1 deficient mouse model of reduced insulin secretion and β-cell mass also exhibits increased autophagy [65] .
The function we propose for GLIS3 in the control of autophagy underlines the complex interplay between cellular mechanisms of recycling or elimination of proteins and cytoplasmic organelles [66] in diabetes and neurodegenerative diseases, including retromer, a cellular mechanism of protein recycling from vacuolar endosomes [67] involving risk genes (SORCS1, VPS10) for T2D and AD [68, 69] , and apoptosis which is stimulated by Glis3 knock-down in INS1 and primary β-cells [28] .
Analysis of the functional consequences of amino-acid changes in GLIS3 caused by GK naturally occurring genetic polymorphisms provided evidence of consistent increased autophagy markers LC3II/I in both rat brain and pancreas. Contrasting effects of GLIS3 on LC3 levels in INS1 and PC12 coincide with differential transcriptional response of Atg7 and Atg4a to stimulation by the BN or GK alleles of Glis3 in these cells, which suggests the involvement of different molecular mediators in GLIS3 function in these cells. Genetic polymorphisms in Glis3 have also been reported in the NOD mouse model of T1D to
contribute to β-cell mass reduction and increased β-cell apoptosis in this strain [70] . In the GK rat, the variants R356C and S851P in GLIS3 may account for the quantitative trait locus for enhanced insulin secretion which we identified in a GKxBN F2 cross to a region of chromosome 1 encompassing Glis3 [32] , validated in the congenics BN.GK-Nidd/gk1 [31] , and fine mapped both in an intercross from BN.GK-Nidd/gk1 rats [71] and in the congenic strain BN.GK-1k in the present study. Their possible roles on increased autophagy in pancreas and brain remain to be replicated in β-cells and in hippocampus in BN.GK-1k and in substrains narrowing the congenic interval to Glis3. These variants may also account for brain anomalies suggesting neurodegeneration in the GK rat, including neuronal loss in the cerebral cortex [72] and decreased dendritic spine density in the hippocampus [73] .
Increased autophagy and co-occurring enhanced insulin secretion mediated by GK GLIS3
variants may represent a mechanism observed in starved INS1 cells [74] that compensates for dramatic β-cell mass reduction in GK rats. We cannot rule out a contribution of other variants in the 1.31Mb GK segment in BN.GK-1k to the regulation of insulin secretion and autophagy. Results from our genome sequencing of the GK/ox colony [38] identified over 3,400 DNA polymorphisms in the GK genomic interval of the congenic strain BN.GK-1k (Table S6) , including four non synonymous variants in AK3 (L123Q), RCL1 (S400I), JAK2
(T469R) and RLN1 (S126G), which might impact phenotypic features of BN.GK-1k rats.
Collectively, results from both cell transfection with GK Glis3 and phenotype analyses in BN.GK-1k support cross-phenotype associations of GLIS3 in GWAS for metabolic diseases and neuropathologies.
Conclusions
Our results provide experimental evidence for a pleiotropic role of GLIS3 in diabetes and neuropathologies and its function in β-cells and neurons. These findings require validation through replication of the ChIPseq experiment with other GLIS3 antibodies and other β-cell Cell-cell signaling (7) 0.017 1.06 HRH1, GRIK1, GRIK3, PDX1, ERC2, NSF, EPHB1 42995 Cell projection (7) 0.028 LZTS1, GRIK1, SLC22A12, GRIK3, BAIAP2, SLC2A2, KATNB1, RHEB, ERC2, NSF, GNAT3
A C C E P T E D M A N U S C R I P T Table 2 . Comparative mapping analysis of GLIS3 binding sites in the human genome. Human orthologs flanking GLIS3 binding sites (G3BS) were searched in the GWAS archive (www.ebi.ac.uk/gwas) for published genetic association with diseases and phenotypes. All GWAS loci that we searched in this catalogue were statistically significant, ie. supported by a p-value <1.0 x 10 -5 in the overall (initial GWAS and replication) population Reference to the G3BS clusters defined in Table S2 is reported in parentheses. Intermediate phenotypes were associated with relevant diseases and categorised as described in Table S4 . GWAS signals for both cardio-metabolic and neurodegenerative/neurobehavioral phenotypes are underlined. A C C E P T E D M A N U S C R I P T
Cardio-metabolic diseases
47
Highlights  GLIS3 binding sites in insulin secreting cells share the motif wrGTTCCCArTAGs  GLIS3 controls the expression of genes involved in autophagy and neuron function  Glis3 sequence polymorphisms in the diabetic GK rat alter β-cell function  Glis3 variants in the GK rat modify neurogenesis in hippocampus neurons
